BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 21792028)

  • 21. Preoperative transcatheter selective arterial chemoembolization in treatment of unresectable hepatoblastoma in infants and children.
    Li JP; Chu JP; Yang JY; Chen W; Wang Y; Huang YH
    Cardiovasc Intervent Radiol; 2008; 31(6):1117-23. PubMed ID: 18560935
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Initial liver transplantation for unresectable hepatoblastoma after chemotherapy.
    Héry G; Franchi-Abella S; Habes D; Brugières L; Martelli H; Fabre M; Pariente D; Gauthier F; Jacquemin E; Branchereau S
    Pediatr Blood Cancer; 2011 Dec; 57(7):1270-5. PubMed ID: 21910210
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Etoposide, cisplatin, epirubicin chemotherapy in the treatment of pediatric liver tumors.
    Casanova M; Massimino M; Ferrari A; Spreafico F; Piva L; Coppa J; Luksch R; Cefalo G; Terenziani M; Polastri D; Bellani FF; Mazzaferro V
    Pediatr Hematol Oncol; 2005; 22(3):189-98. PubMed ID: 16020101
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficiency and toxicity of ifosfamide, cisplatin and doxorubicin in the treatment of childhood hepatoblastoma. Study Committee of the Cooperative Paediatric Liver Tumour Study HB89 of the German Society for Paediatric Oncology and Haematology.
    von Schweinitz D; Byrd DJ; Hecker H; Weinel P; Bode U; Bürger D; Erttmann R; Harms D; Mildenberger H
    Eur J Cancer; 1997 Jul; 33(8):1243-9. PubMed ID: 9301450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Fetal and neonatal hepatic tumors.
    Isaacs H
    J Pediatr Surg; 2007 Nov; 42(11):1797-803. PubMed ID: 18022426
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vinorelbine and cisplatin (CIVIC regimen) for the treatment of metastatic breast carcinoma after failure of anthracycline- and/or paclitaxel-containing regimens.
    Ray-Coquard I; Biron P; Bachelot T; Guastalla JP; Catimel G; Merrouche Y; Droz JP; Chauvin F; Blay JY
    Cancer; 1998 Jan; 82(1):134-40. PubMed ID: 9428489
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: a SIOP pilot study.
    Ninane J; Perilongo G; Stalens JP; Guglielmi M; Otte JB; Mancini A
    Med Pediatr Oncol; 1991; 19(3):199-203. PubMed ID: 1850817
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose-dense cisplatin-based chemotherapy and surgery for children with high-risk hepatoblastoma (SIOPEL-4): a prospective, single-arm, feasibility study.
    Zsiros J; Brugieres L; Brock P; Roebuck D; Maibach R; Zimmermann A; Childs M; Pariente D; Laithier V; Otte JB; Branchereau S; Aronson D; Rangaswami A; Ronghe M; Casanova M; Sullivan M; Morland B; Czauderna P; Perilongo G;
    Lancet Oncol; 2013 Aug; 14(9):834-42. PubMed ID: 23831416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of modified MAID regimen for patients with advanced soft tissue sarcoma].
    Li EX; Zhang YT; Shang JT; Xu Z; Geng Y; Li SM; Shi F; Wu YY
    Ai Zheng; 2006 Aug; 25(8):1048-51. PubMed ID: 16965692
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pretreatment prognostic factors and treatment results in children with hepatoblastoma: a report from the German Cooperative Pediatric Liver Tumor Study HB 94.
    Fuchs J; Rydzynski J; Von Schweinitz D; Bode U; Hecker H; Weinel P; Bürger D; Harms D; Erttmann R; Oldhafer K; Mildenberger H;
    Cancer; 2002 Jul; 95(1):172-82. PubMed ID: 12115331
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low incidence of ototoxicity with continuous infusion of cisplatin in the treatment of pediatric germ cell tumors.
    Gupta AA; Capra M; Papaioannou V; Hall G; Maze R; Dix D; Weitzman S
    J Pediatr Hematol Oncol; 2006 Feb; 28(2):91-4. PubMed ID: 16462581
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Successful treatment of doxorubicin and cisplatin resistant hepatoblastoma in a child with Beckwith-Wiedemann syndrome with high dose acetaminophen and N-acetylcysteine rescue.
    Kobrinsky NL; Sjolander DE; Goldenberg JA; Ortmeier TC
    Pediatr Blood Cancer; 2005 Aug; 45(2):222-5. PubMed ID: 15770640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.
    Ferrari S; Smeland S; Mercuri M; Bertoni F; Longhi A; Ruggieri P; Alvegard TA; Picci P; Capanna R; Bernini G; Müller C; Tienghi A; Wiebe T; Comandone A; Böhling T; Del Prever AB; Brosjö O; Bacci G; Saeter G;
    J Clin Oncol; 2005 Dec; 23(34):8845-52. PubMed ID: 16246977
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Treatment of unresectable and metastatic hepatoblastoma: a pediatric oncology group phase II study.
    Katzenstein HM; London WB; Douglass EC; Reynolds M; Plaschkes J; Finegold MJ; Bowman LC
    J Clin Oncol; 2002 Aug; 20(16):3438-44. PubMed ID: 12177104
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful liver transplant for unresectable hepatoblastoma.
    Casas-Melley AT; Malatack J; Consolini D; Mann K; Raab C; Flynn L; Woolfrey P; Menendez J; Dunn SP
    J Pediatr Surg; 2007 Jan; 42(1):184-7. PubMed ID: 17208562
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Continuous or repeated prolonged cisplatin infusions in children: a prospective study on ototoxicity, platinum concentrations, and standard serum parameters.
    Lanvers-Kaminsky C; Krefeld B; Dinnesen AG; Deuster D; Seifert E; Würthwein G; Jaehde U; Pieck AC; Boos J
    Pediatr Blood Cancer; 2006 Aug; 47(2):183-93. PubMed ID: 16302218
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phase II trial of paclitaxel by 96-hour continuous infusion in combination with cisplatin for patients with advanced non-small cell lung cancer.
    Breathnach OS; Georgiadis MS; Schuler BS; Pizzella P; Llorens V; Kasturi V; Steinberg SM; O'Neil K; Takimoto CH; Johnson BE
    Clin Cancer Res; 2000 Jul; 6(7):2670-6. PubMed ID: 10914708
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Therapeutic efficacy of multimodal combination therapy using transcatheter arterial infusion of epirubicin and cisplatin, systemic infusion of 5-fluorouracil, and additional percutaneous ethanol injection for unresectable hepatocellular carcinoma.
    Jang JW; Park YM; Bae SH; Choi JY; Yoon SK; Chang UI; Nam SW; Kim BS
    Cancer Chemother Pharmacol; 2004 Nov; 54(5):415-20. PubMed ID: 15235823
    [TBL] [Abstract][Full Text] [Related]  

  • 39. First-line protracted venous infusion fluorouracil with CisDDP or carboplatin in advanced colorectal cancer.
    Garcia-Giralt E; Beuzeboc P; Deffontaines D; Diéras V; Dorval T; Jouve M; Palangie T; Scholl S; Pouillart P
    J Infus Chemother; 1996; 6(3):149-51. PubMed ID: 9229328
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Phase II trial combining paclitaxel with 24-hour infusion cisplatin for chemotherapy-naïve patients with locally advanced or metastatic breast carcinoma.
    Hsu C; Huang CS; Chao TY; Lu YS; Bu CF; Chen MM; Chang KJ; Cheng AL
    Cancer; 2002 Nov; 95(10):2044-50. PubMed ID: 12412156
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.